Engine Room Partners reported a $7.5 million private placement into a cancer therapy company.
Public source
Publisher name
Public post
Markets fell for a third straight day yesterday. Oil spiked past $94 after tanker strikes near the Strait of Hormuz. The 10-year hit a twenty-month high. On the surface,…
Company
Engine Room Partners
Senior marketing leadership for companies ready to build a governed growth engine.
- Company size
- 1 employee
About Engine Room Partners
Engine Room Partners provides embedded senior marketing leadership for companies that need more than marketing activity. They need a growth system. We work alongside leadership teams to architect and govern the systems responsible for producing growth—aligning strategy, positioning, marketing, sales, technology, data, teams, and execution around shared business priorities. Our role is not to replace every function inside the organization or operate as another outside agency. We provide the senior marketing leadership needed to connect those functions, establish accountability, improve decision-making, and turn fragmented activity into a coordinated growth engine. Through the Marketing Engine Room™, we bring structure to how growth is planned, governed, measured, and improved. Align the strategy. Govern the system. Build what drives growth.
See moreLatest activity
Latest activity from Engine Room Partners
10 signals
Presence & Recognition
Engine Room Partners announced a Google event called Rethink ROI focused on AI powered lead to sale journeys and better measurement.
People
Engine Room Partners was built to connect company direction with marketing strategy, sales priorities, customer intelligence, operational realities, outside partners, and performance data.
People
Engine Room Partners was built by Mark Powers as an embedded fractional CMO running The Marketing Engine Room.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
N-Power Medicine, Inc.
N-Power Medicine, Inc. closed a $32 million Series B financing round to expand its community oncology network and accelerate the adoption of ProECA.
Capital & Finance
Foresite Capital
Foresite Capital announced the launch of a $125M+ Series E funding round and the launch of Thyme Companies to expand their impact and reach across the cancer care landscape.
Capital & Finance
Cancer Research Horizons
Cancer Research Horizons leveraged more than £3.5bn in additional investment to support the development of new cancer innovations.
Capital & Finance
Frist Cressey Ventures
Frist Cressey Ventures launched Series E funding and Thyme Companies to extend the model into drug affordability, clinical trial access, and other oncology parts that fee-for-service was never built to fix.
Capital & Finance
TILT Biotherapeutics Ltd